UNSPSC 51283942: Sulfachrysoidine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C13H13N5O4S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 39O1389K38, chemically known as 4,6-diamino-4-sulfamoylazobenzol-2-carbonsaeure but more generally known as sulfachrysoidine, which bears U.S. National Institutes of Health Compound Identifier 68090. The European Medicines Agency schedules Sulfachrysoidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10689MIG.

UNSPSC 51283942 Sulfachrysoidine (Commodity) does not reflect the work actually being solicited under this code in recent state and local procurement. The four recent opportunities tagged to this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives, emergency medical and first aid supplies, and generic pharmaceuticals and OTC products — none of which are sulfachrysoidine, an organic dye compound. The code shows a classification mismatch: state and local issuing bodies are not procuring sulfachrysoidine as a standalone commodity, and no recent opportunities support active buying in this product category.

The opportunities posted under this code between January and June 2026 reflect state and local demand for pharmaceutical distribution, emergency medical supplies, and pharmacy benefit program infrastructure rather than chemical dyes or industrial colorants. Seminole County, Florida solicited naloxone and drug deactivation systems through IFB 60459723LAS (due July 26, 2023); the City of Tampa issued IFB 26-P-00145 for medical and first aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 and a March 13, 2026 deadline; the Texas Health and Human Services Commission posted RFI HHS0017013 to gather market intelligence on direct-to-manufacturer prescription programs (April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The code does not show active state and local procurement interest in sulfachrysoidine or related dye compounds, and the recent opportunities appear to be mis-tagged to this code.